Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Reported variability in healthcare facility policies regarding healthcare personnel working while experiencing influenza-like illnesses: An emerging infections network survey.

Babcock HM, Beekmann SE, Pillai SK, Santibanez S, Lee L, Kuhar DT, Campbell AP, Patel A, Polgreen PM.

Infect Control Hosp Epidemiol. 2019 Nov 14:1-6. doi: 10.1017/ice.2019.305. [Epub ahead of print]

PMID:
31722757
2.

Lessons from the reestablishment of Public Health Laboratory activities in Puerto Rico after Hurricane Maria.

Hardy MC, Stinnett RC, Kines KJ, Rivera-Nazario DM, Lowe DE, Mercante AM, Gonzalez Jimenez N, Cuevas Ruiz RI, Rivera Arbolay HI, Gonzalez Peña RL, Toro M, Trujillo AA, Pappas CL, Llewellyn AC, Candal F, Burgos Garay M, Gomez GA, Concepcion Acevedo J, Ansbro M, Moura H, Shaw MW, Muehlenbachs A, Romanoff LC, Sunshine BJ, Rose DA, Patel A, Shapiro CN, Luna-Pinto SC, Pillai SK, O'Neill E.

Nat Commun. 2019 Jun 20;10(1):2720. doi: 10.1038/s41467-019-10776-y. Review.

3.

Role of C-reactive Protein as an Indicator for Determining the Outcome of Sepsis.

Anush MM, Ashok VK, Sarma RI, Pillai SK.

Indian J Crit Care Med. 2019 Jan;23(1):11-14. doi: 10.5005/jp-journals-10071-23105.

4.

Approach to Prioritizing Respiratory Protection When Demand Exceeds Supplies During an Influenza Pandemic: A Call to Action.

Patel A, Lee L, Pillai SK, Valderrama AL, Delaney LJ, Radonovich L.

Health Secur. 2019 Mar/Apr;17(2):152-155. doi: 10.1089/hs.2019.0027. No abstract available.

PMID:
31009256
5.

Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency.

Li Z, Wu J, Chavez L, Hoh R, Deeks SG, Pillai SK, Zhou Q.

PLoS Pathog. 2019 Jan 15;15(1):e1007498. doi: 10.1371/journal.ppat.1007498. eCollection 2019 Jan.

6.

Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.

Premeaux TA, D'Antoni ML, Abdel-Mohsen M, Pillai SK, Kallianpur KJ, Nakamoto BK, Agsalda-Garcia M, Shiramizu B, Shikuma CM, Gisslén M, Price RW, Valcour V, Ndhlovu LC.

J Neurovirol. 2019 Apr;25(2):150-161. doi: 10.1007/s13365-018-0696-3. Epub 2018 Nov 26.

PMID:
30478799
7.

Serious life-threatening multifocal infection in a child, caused by Panton-Valentine leucocidin-producing Staphylococcus aureus (PVL-MSSA).

Irenji N, Pillai SKG, West-Jones JS.

BMJ Case Rep. 2018 Jun 5;2018. pii: bcr-2017-222138. doi: 10.1136/bcr-2017-222138.

PMID:
29871957
8.

Granulocyte-Derived Extracellular Vesicles Activate Monocytes and Are Associated With Mortality in Intensive Care Unit Patients.

Danesh A, Inglis HC, Abdel-Mohsen M, Deng X, Adelman A, Schechtman KB, Heitman JW, Vilardi R, Shah A, Keating SM, Cohen MJ, Jacobs ES, Pillai SK, Lacroix J, Spinella PC, Norris PJ.

Front Immunol. 2018 May 8;9:956. doi: 10.3389/fimmu.2018.00956. eCollection 2018.

9.

Distinct chromatin functional states correlate with HIV latency reactivation in infected primary CD4+ T cells.

Battivelli E, Dahabieh MS, Abdel-Mohsen M, Svensson JP, Tojal Da Silva I, Cohn LB, Gramatica A, Deeks S, Greene WC, Pillai SK, Verdin E.

Elife. 2018 May 1;7. pii: e34655. doi: 10.7554/eLife.34655.

10.

Notes from the Field: Pharmacy Needs After a Natural Disaster - Puerto Rico, September-October 2017.

Lavery AM, Patel A, Boehmer TK, Lee L, Bhavsar T, Thomas J, Hall L, Beavers S, Murray M, Pillai SK.

MMWR Morb Mortal Wkly Rep. 2018 Apr 6;67(13):402-403. doi: 10.15585/mmwr.mm6713a4. No abstract available.

11.

Initial Public Health Laboratory Response After Hurricane Maria - Puerto Rico, 2017.

Concepción-Acevedo J, Patel A, Luna-Pinto C, Peña RG, Cuevas Ruiz RI, Arbolay HR, Toro M, Deseda C, De Jesus VR, Ribot E, Gonzalez JQ, Rao G, De Leon Salazar A, Ansbro M, White BB, Hardy MC, Georgi JC, Stinnett R, Mercante AM, Lowe D, Martin H, Starks A, Metchock B, Johnston S, Dalton T, Joglar O, Stafford C, Youngblood M, Klein K, Lindstrom S, Berman L, Galloway R, Schafer IJ, Walke H, Stoddard R, Connelly R, McCaffery E, Rowlinson MC, Soroka S, Tranquillo DT, Gaynor A, Mangal C, Wroblewski K, Muehlenbachs A, Salerno RM, Lozier M, Sunshine B, Shapiro C, Rose D, Funk R, Pillai SK, O'Neill E.

MMWR Morb Mortal Wkly Rep. 2018 Mar 23;67(11):333-336. doi: 10.15585/mmwr.mm6711a5.

12.

The Epidemiology of Foodborne Botulism Outbreaks: A Systematic Review.

Fleck-Derderian S, Shankar M, Rao AK, Chatham-Stephens K, Adjei S, Sobel J, Meltzer MI, Meaney-Delman D, Pillai SK.

Clin Infect Dis. 2017 Dec 27;66(suppl_1):S73-S81. doi: 10.1093/cid/cix846.

PMID:
29293934
13.

CDC Safety Training Course for Ebola Virus Disease Healthcare Workers.

Narra R, Sobel J, Piper C, Gould D, Bhadelia N, Dott M, Fiore A, Fischer WA 2nd, Frawley MJ, Griffin PM, Hamilton D, Mahon B, Pillai SK, Veltus EF, Tauxe R, Jhung M.

Emerg Infect Dis. 2017 Dec;23(13). doi: 10.3201/eid2313.170549.

14.

Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy.

Bangirana P, Ruel TD, Boivin MJ, Pillai SK, Giron LB, Sikorskii A, Banik A, Achan J.

J Int AIDS Soc. 2017 Oct;20(2). doi: 10.1002/jia2.25015.

15.

The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon.

Krarup AR, Abdel-Mohsen M, Schleimann MH, Vibholm L, Engen PA, Dige A, Wittig B, Schmidt M, Green SJ, Naqib A, Keshavarzian A, Deng X, Olesen R, Petersen AM, Benfield T, Østergaard L, Rasmussen TA, Agnholt J, Nyengaard JR, Landay A, Søgaard OS, Pillai SK, Tolstrup M, Denton PW.

Mucosal Immunol. 2018 Mar;11(2):449-461. doi: 10.1038/mi.2017.59. Epub 2017 Aug 2.

16.

Identification and characterization of a rich population of CD34+ mesenchymal stem/stromal cells in human parotid, sublingual and submandibular glands.

Togarrati PP, Sasaki RT, Abdel-Mohsen M, Dinglasan N, Deng X, Desai S, Emmerson E, Yee E, Ryan WR, da Silva MCP, Knox SM, Pillai SK, Muench MO.

Sci Rep. 2017 Jun 14;7(1):3484. doi: 10.1038/s41598-017-03681-1.

17.

A Prospective Study of Level IIB Nodal Metastasis (Supraretrospinal) in Clinically N0 Oral Squamous Cell Carcinoma in Indian Population.

Chheda YP, Pillai SK, Parikh DG, Dipayan N, Shah SV, Alaknanda G.

Indian J Surg Oncol. 2017 Jun;8(2):105-108. doi: 10.1007/s13193-014-0359-7. Epub 2014 Nov 13.

18.

Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.

Henrich TJ, Deeks SG, Pillai SK.

J Infect Dis. 2017 Mar 15;215(suppl_3):S134-S141. doi: 10.1093/infdis/jiw648. Review.

19.

Signature of the Sleeper Cell: A Biomarker of HIV Latency Revealed.

Pillai SK, Deeks SG.

Trends Immunol. 2017 Jul;38(7):457-458. doi: 10.1016/j.it.2017.04.007. Epub 2017 May 13.

20.

HIV Antibody Level as a Marker of HIV Persistence and Low-Level Viral Replication.

Keating SM, Pilcher CD, Jain V, Lebedeva M, Hampton D, Abdel-Mohsen M, Deng X, Murphy G, Welte A, Facente SN, Hecht F, Deeks SG, Pillai SK, Busch MP.

J Infect Dis. 2017 Jul 1;216(1):72-81. doi: 10.1093/infdis/jix225.

21.

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.

Vibholm L, Schleimann MH, Højen JF, Benfield T, Offersen R, Rasmussen K, Olesen R, Dige A, Agnholt J, Grau J, Buzon M, Wittig B, Lichterfeld M, Petersen AM, Deng X, Abdel-Mohsen M, Pillai SK, Rutsaert S, Trypsteen W, De Spiegelaere W, Vandekerchove L, Østergaard L, Rasmussen TA, Denton PW, Tolstrup M, Søgaard OS.

Clin Infect Dis. 2017 Jun 15;64(12):1686-1695. doi: 10.1093/cid/cix201.

22.

Zika Virus -10 Public Health Achievements in 2016 and Future Priorities.

Oussayef NL, Pillai SK, Honein MA, Ben Beard C, Bell B, Boyle CA, Eisen LM, Kohl K, Kuehnert MJ, Lathrop E, Martin SW, Martin R, McAllister JC, McClune EP, Mead P, Meaney-Delman D, Petersen B, Petersen LR, Polen KN, Powers AM, Redd SC, Sejvar JJ, Sharp T, Villanueva J, Jamieson DJ.

MMWR Morb Mortal Wkly Rep. 2017 Jan 6;65(52):1482-1488. doi: 10.15585/mmwr.mm6552e1.

23.

Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression.

Jacobs ES, Keating SM, Abdel-Mohsen M, Gibb SL, Heitman JW, Inglis HC, Martin JN, Zhang J, Kaidarova Z, Deng X, Wu S, Anastos K, Crystal H, Villacres MC, Young M, Greenblatt RM, Landay AL, Gange SJ, Deeks SG, Golub ET, Pillai SK, Norris PJ.

J Virol. 2017 Feb 28;91(6). pii: e02051-16. doi: 10.1128/JVI.02051-16. Print 2017 Mar 15.

24.

Totally embedded hybrid thin films of carbon nanotubes and silver nanowires as flat homogenous flexible transparent conductors.

Pillai SKR, Wang J, Wang Y, Sk MM, Prakoso AB, Rusli, Chan-Park MB.

Sci Rep. 2016 Dec 8;6:38453. doi: 10.1038/srep38453.

25.

Update: Interim Guidance for Preconception Counseling and Prevention of Sexual Transmission of Zika Virus for Persons with Possible Zika Virus Exposure - United States, September 2016.

Petersen EE, Meaney-Delman D, Neblett-Fanfair R, Havers F, Oduyebo T, Hills SL, Rabe IB, Lambert A, Abercrombie J, Martin SW, Gould CV, Oussayef N, Polen KN, Kuehnert MJ, Pillai SK, Petersen LR, Honein MA, Jamieson DJ, Brooks JT.

MMWR Morb Mortal Wkly Rep. 2016 Oct 7;65(39):1077-1081. doi: 10.15585/mmwr.mm6539e1.

26.

Update: Interim Guidance for Health Care Providers Caring for Pregnant Women with Possible Zika Virus Exposure - United States, July 2016.

Oduyebo T, Igbinosa I, Petersen EE, Polen KN, Pillai SK, Ailes EC, Villanueva JM, Newsome K, Fischer M, Gupta PM, Powers AM, Lampe M, Hills S, Arnold KE, Rose LE, Shapiro-Mendoza CK, Beard CB, Muñoz JL, Rao CY, Meaney-Delman D, Jamieson DJ, Honein MA.

MMWR Morb Mortal Wkly Rep. 2016 Jul 25;65(29):739-44. doi: 10.15585/mmwr.mm6529e1.

27.

Secondary Infections with Ebola Virus in Rural Communities, Liberia and Guinea, 2014-2015.

Lindblade KA, Nyenswah T, Keita S, Diallo B, Kateh F, Amoah A, Nagbe TK, Raghunathan P, Neatherlin JC, Kinzer M, Pillai SK, Attfield KR, Hajjeh R, Dweh E, Painter J, Barradas DT, Williams SG, Blackley DJ, Kirking HL, Patel MR, Dea M, Massoudi MS, Barskey AE, Zarecki SL, Fomba M, Grube S, Belcher L, Broyles LN, Maxwell TN, Hagan JE, Yeoman K, Westercamp M, Mott J, Mahoney F, Slutsker L, DeCock KM, Marston B, Dahl B.

Emerg Infect Dis. 2016 Sep;22(9):1653-5. doi: 10.3201/eid2209.160416. Epub 2016 Sep 15.

28.

Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation.

Abdel-Mohsen M, Chavez L, Tandon R, Chew GM, Deng X, Danesh A, Keating S, Lanteri M, Samuels ML, Hoh R, Sacha JB, Norris PJ, Niki T, Shikuma CM, Hirashima M, Deeks SG, Ndhlovu LC, Pillai SK.

PLoS Pathog. 2016 Jun 2;12(6):e1005677. doi: 10.1371/journal.ppat.1005677. eCollection 2016 Jun.

29.

Identifying Meningitis During an Anthrax Mass Casualty Incident: Systematic Review of Systemic Anthrax Since 1880.

Katharios-Lanwermeyer S, Holty JE, Person M, Sejvar J, Haberling D, Tubbs H, Meaney-Delman D, Pillai SK, Hupert N, Bower WA, Hendricks K.

Clin Infect Dis. 2016 Jun 15;62(12):1537-1545. doi: 10.1093/cid/ciw184. Epub 2016 Mar 29. Review.

30.

Ebola and Its Control in Liberia, 2014-2015.

Nyenswah TG, Kateh F, Bawo L, Massaquoi M, Gbanyan M, Fallah M, Nagbe TK, Karsor KK, Wesseh CS, Sieh S, Gasasira A, Graaff P, Hensley L, Rosling H, Lo T, Pillai SK, Gupta N, Montgomery JM, Ransom RL, Williams D, Laney AS, Lindblade KA, Slutsker L, Telfer JL, Christie A, Mahoney F, De Cock KM.

Emerg Infect Dis. 2016 Feb;22(2):169-77. doi: 10.3201/eid2202.151456.

31.

Antitoxin Treatment of Inhalation Anthrax: A Systematic Review.

Huang E, Pillai SK, Bower WA, Hendricks KA, Guarnizo JT, Hoyle JD, Gorman SE, Boyer AE, Quinn CP, Meaney-Delman D.

Health Secur. 2015 Nov-Dec;13(6):365-77. doi: 10.1089/hs.2015.0032. Review.

32.

Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review.

Pillai SK, Huang E, Guarnizo JT, Hoyle JD, Katharios-Lanwermeyer S, Turski TK, Bower WA, Hendricks KA, Meaney-Delman D.

Health Secur. 2015 Nov-Dec;13(6):355-64. doi: 10.1089/hs.2015.0033. Epub 2015 Dec 1. Review.

33.

Decreased Ebola Transmission after Rapid Response to Outbreaks in Remote Areas, Liberia, 2014.

Lindblade KA, Kateh F, Nagbe TK, Neatherlin JC, Pillai SK, Attfield KR, Dweh E, Barradas DT, Williams SG, Blackley DJ, Kirking HL, Patel MR, Dea M, Massoudi MS, Wannemuehler K, Barskey AE, Zarecki SL, Fomba M, Grube S, Belcher L, Broyles LN, Maxwell TN, Hagan JE, Yeoman K, Westercamp M, Forrester J, Mott J, Mahoney F, Slutsker L, DeCock KM, Nyenswah T.

Emerg Infect Dis. 2015 Oct;21(10):1800-7. doi: 10.3201/eid2110.150912.

34.

Elimination of Ebola Virus Transmission in Liberia - September 3, 2015.

Bawo L, Fallah M, Kateh F, Nagbe T, Clement P, Gasasira A, Mahmoud N, Musa E, Lo TQ, Pillai SK, Seeman S, Sunshine BJ, Weidle PJ, Nyensweh T; Liberia Ministry of Health; World Health Organization; CDC Ebola Response Teams.

MMWR Morb Mortal Wkly Rep. 2015 Sep 11;64(35):979-80. doi: 10.15585/mmwr.mm6435a5.

35.

TIMP3 Attenuates the Loss of Neural Stem Cells, Mature Neurons and Neurocognitive Dysfunction in Traumatic Brain Injury.

Gibb SL, Zhao Y, Potter D, Hylin MJ, Bruhn R, Baimukanova G, Zhao J, Xue H, Abdel-Mohsen M, Pillai SK, Moore AN, Johnson EM, Cox CS Jr, Dash PK, Pati S.

Stem Cells. 2015 Dec;33(12):3530-44. doi: 10.1002/stem.2189. Epub 2015 Oct 23.

36.

Clinician Beliefs and Attitudes Regarding Use of Respiratory Protective Devices and Surgical Masks for Influenza.

Pillai SK, Beekmann SE, Babcock HM, Pavia AT, Koonin LM, Polgreen PM.

Health Secur. 2015 Jul-Aug;13(4):274-80. doi: 10.1089/hs.2015.0011. Epub 2015 Jul 14.

37.

Carbon Nanotube Driver Circuit for 6 × 6 Organic Light Emitting Diode Display.

Zou J, Zhang K, Li J, Zhao Y, Wang Y, Pillai SK, Volkan Demir H, Sun X, Chan-Park MB, Zhang Q.

Sci Rep. 2015 Jun 29;5:11755. doi: 10.1038/srep11755.

38.

Potential demand for respirators and surgical masks during a hypothetical influenza pandemic in the United States.

Carias C, Rainisch G, Shankar M, Adhikari BB, Swerdlow DL, Bower WA, Pillai SK, Meltzer MI, Koonin LM.

Clin Infect Dis. 2015 May 1;60 Suppl 1:S42-51. doi: 10.1093/cid/civ141.

PMID:
25878300
39.

Evolution of ebola virus disease from exotic infection to global health priority, Liberia, mid-2014.

Arwady MA, Bawo L, Hunter JC, Massaquoi M, Matanock A, Dahn B, Ayscue P, Nyenswah T, Forrester JD, Hensley LE, Monroe B, Schoepp RJ, Chen TH, Schaecher KE, George T, Rouse E, Schafer IJ, Pillai SK, De Cock KM.

Emerg Infect Dis. 2015 Apr;21(4):578-84. doi: 10.3201/eid2104.141940.

40.

Antiviral gene expression in psoriasis.

Raposo RA, Gupta R, Abdel-Mohsen M, Dimon M, Debbaneh M, Jiang W, York VA, Leadabrand KS, Brown G, Malakouti M, Arron S, Kuebler PJ, Wu JJ, Pillai SK, Nixon DF, Liao W.

J Eur Acad Dermatol Venereol. 2015 Oct;29(10):1951-7. doi: 10.1111/jdv.13091. Epub 2015 Mar 23.

41.

Implementation of Ebola case-finding using a village chieftaincy taskforce in a remote outbreak - Liberia, 2014.

Hagan JE, Smith W, Pillai SK, Yeoman K, Gupta S, Neatherlin J, Slutsker L, Lindblade KA, DeCock KM, Kateh F, Nyenswah T; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Feb 27;64(7):183-5.

42.

Rapid intervention to reduce Ebola transmission in a remote village - Gbarpolu County, Liberia, 2014.

Blackley DJ, Lindblade KA, Kateh F, Broyles LN, Westercamp M, Neatherlin JC, Pillai SK, Tucker A, Mott JA, Walke H, Nyenswah T; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Feb 27;64(7):175-8.

43.

Select host restriction factors are associated with HIV persistence during antiretroviral therapy.

Abdel-Mohsen M, Wang C, Strain MC, Lada SM, Deng X, Cockerham LR, Pilcher CD, Hecht FM, Liegler T, Richman DD, Deeks SG, Pillai SK.

AIDS. 2015 Feb 20;29(4):411-20. doi: 10.1097/QAD.0000000000000572.

44.

Ebola virus disease cases among health care workers not working in Ebola treatment units--Liberia, June-August, 2014.

Matanock A, Arwady MA, Ayscue P, Forrester JD, Gaddis B, Hunter JC, Monroe B, Pillai SK, Reed C, Schafer IJ, Massaquoi M, Dahn B, De Cock KM; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Nov 21;63(46):1077-81.

45.

Intermittent facial swelling.

Pope C, Pillai SK.

BMJ Case Rep. 2014 Oct 17;2014. pii: bcr2013202355. doi: 10.1136/bcr-2013-202355.

46.

Developing an incident management system to support Ebola response -- Liberia, July-August 2014.

Pillai SK, Nyenswah T, Rouse E, Arwady MA, Forrester JD, Hunter JC, Matanock A, Ayscue P, Monroe B, Schafer IJ, Poblano L, Neatherlin J, Montgomery JM, De Cock KM; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Oct 17;63(41):930-3.

47.

Cluster of Ebola cases among Liberian and U.S. health care workers in an Ebola treatment unit and adjacent hospital -- Liberia, 2014.

Forrester JD, Hunter JC, Pillai SK, Arwady MA, Ayscue P, Matanock A, Monroe B, Schafer IJ, Nyenswah TG, De Cock KM; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Oct 17;63(41):925-9.

48.

Assessment of ebola virus disease, health care infrastructure, and preparedness - four counties,Southeastern Liberia, august 2014.

Forrester JD, Pillai SK, Beer KD, Neatherlin J, Massaquoi M, Nyenswah TG, Montgomery JM, De Cock K; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2014 Oct 10;63(40):891-3.

49.

Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo.

Abdel-Mohsen M, Deng X, Danesh A, Liegler T, Jacobs ES, Rauch A, Ledergerber B, Norris PJ, Günthard HF, Wong JK, Pillai SK.

PLoS One. 2014 Oct 2;9(10):e109220. doi: 10.1371/journal.pone.0109220. eCollection 2014.

50.

Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo.

Raposo RA, Abdel-Mohsen M, Deng X, Hecht FM, Pilcher CD, Pillai SK, Nixon DF.

J Virol. 2014 Oct;88(19):11624-9. doi: 10.1128/JVI.01771-14. Epub 2014 Jul 16.

Supplemental Content

Loading ...
Support Center